Altern Ther Health Med. 2023 Oct;29(7):252-261.
Upper respiratory tract infections (URTIs) are one of the most common illnesses in humans. Unani medications are widely used for this indication and are considered effective in alleviating the symptoms.
This article aims to document the Unani medications used for URTIs under a single heading and to provide evidence of their efficacy.
A literature survey of classic Unani texts was conducted to screen for single and compound Unani formulations for URTIs. Electronic databases such as PubMed, ScienceDirect, Wiley Online Library, and Google Scholar were searched to obtain evidence regarding the efficacy of these recommended drugs in URTI treatment.
In the Unani medicine literature, the authors found descriptions of 28 single herbs and 40 compound formulations for the treatment of URTIs. A search of electronic databases yielded 13 clinical studies confirming the efficacy of the recommended medications in URTI treatment. These trials demonstrated that the administration of Unani medications significantly accelerated clinical improvement in URTIs.
The findings of the included studies led us to conclude that the use of Unani medicines significantly accelerates clinical improvement in URTIs, as demonstrated by various subjective and objective parameters. Hence, clinically validated Unani medications should be considered for the treatment of URTIs.
上呼吸道感染（URTIs）是人类最常见的疾病之一。顺势疗法药物被广泛用于该适应症，并被认为能有效缓解症状。
本文旨在记录顺势疗法药物用于 URTIs 的单一适应症，并提供其疗效的证据。
对经典顺势疗法文本进行文献调查，以筛选用于 URTIs 的单一和复方顺势疗法制剂。检索 PubMed、ScienceDirect、Wiley Online Library 和 Google Scholar 等电子数据库，以获取关于这些推荐药物在 URTI 治疗中疗效的证据。
在顺势疗法医学文献中，作者发现了 28 种单味草药和 40 种复方制剂用于治疗 URTIs 的描述。电子数据库的搜索产生了 13 项临床研究，证实了推荐药物在 URTI 治疗中的疗效。这些试验表明，顺势疗法药物的给药显著加速了 URTIs 的临床改善。
纳入研究的结果使我们得出结论，顺势疗法药物的使用显著加速了 URTIs 的临床改善，这可以通过各种主观和客观参数来证明。因此，应考虑将经过临床验证的顺势疗法药物用于 URTIs 的治疗。
